Synthesis and Characterization of Magnetic Drug Carriers Modified with Tb3+ Ions

  • Nieciecka D
  • Rękorajska A
  • Cichy D
  • et al.
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The study aimed to synthesize and characterize the magnetic drug carrier modified with terbium (III) ions. The addition of terbium extends the possibilities of their applications for targeted anticancer radiotherapy as well as for imaging techniques using radioisotopes emitting β+, β−, α, and γ radiation. The synthesis of iron oxide nanoparticles stabilized with citrates using the co-precipitation method (IONP @ CA) was carried out during the experimental work. The obtained nanoparticles were used to synthesize a conjugate containing terbium ions and guanosine-5′-monophosphate as an analog of drugs from the thiopurine group. Conjugates and their components were characterized using Transmission Electron Microscopy, infrared spectroscopy, X-ray microanalysis, spectrofluorimetry, and thermogravimetric analysis. The hybrid was also investigated with Langmuir layers to check the interaction with analogs of biological membranes.

Cite

CITATION STYLE

APA

Nieciecka, D., Rękorajska, A., Cichy, D., Końska, P., Żuk, M., & Krysiński, P. (2022). Synthesis and Characterization of Magnetic Drug Carriers Modified with Tb3+ Ions. Nanomaterials, 12(5), 795. https://doi.org/10.3390/nano12050795

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free